Form 4: Elanco Animal Health Executive Timothy Bettington Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
Timothy Bettington, an Executive Vice President at Elanco Animal Health, was granted stock options and restricted stock units on March 1, 2024.
Summary
- On March 1, 2024, Timothy Bettington, Executive Vice President at Elanco Animal Health, received 21,835 restricted stock units.
- These restricted stock units vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.
- Bettington also received stock options for 47,620 shares with an exercise price of $16.03.
- These options also vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027, and expire on March 1, 2034.
- Following these transactions, Bettington beneficially owns 129,944 shares of Elanco Animal Health stock and 47,620 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The grant of stock options and restricted stock units is a standard practice and indicates confidence in the executive and the company's future performance.
Positives
- The grant of restricted stock units and stock options aligns Mr. Bettington's interests with those of the shareholders, incentivizing him to drive long-term value for the company.
- The vesting schedule encourages continued service and commitment to Elanco Animal Health over the next three years.
Future Outlook
The vesting schedule of the restricted stock units and stock options suggests a continued commitment from Timothy Bettington to Elanco Animal Health for the next three years.
Industry Context
Stock option and restricted stock unit grants are a common practice in the animal health industry to incentivize and retain key executives. This grant is consistent with standard compensation practices.
Comparison to Industry Standards
- Comparing Elanco's executive compensation structure to peers like Zoetis and Merck Animal Health, stock options and restricted stock units are standard components of executive pay.
- The vesting schedules are also typical, aligning with industry norms for long-term incentive plans.
Stakeholder Impact
- Shareholders may view this as a positive sign, indicating that the company is investing in its leadership and aligning their interests with shareholder value.
- Employees may see this as a sign of stability and commitment to the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of transaction: Grant of restricted stock units and stock options. |
| 03/01/2025 | First vesting date for one-third of the restricted stock units and stock options. |
| 03/01/2026 | Second vesting date for one-third of the restricted stock units and stock options. |
| 03/01/2027 | Final vesting date for the remaining restricted stock units and stock options. |
| 03/01/2034 | Expiration date of the stock options. |
| 03/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.